Nutex Health Inc. reported a total revenue of $216.5 million for the first quarter of 2026, marking a 2.3% increase from $211.8 million in the same period of 2025. The hospital division generated $207.6 million, up from $203.9 million, while the population health management division contributed $8.9 million, compared to $7.8 million a year earlier. The company achieved a net income of $62.8 million, or $6.52 per diluted share, significantly higher than the $50.8 million, or $3.33 per diluted share, reported in the prior year. This increase in profitability was attributed to higher patient visits and improved cash collections, despite a decrease in net revenue per visit.
Operationally, Nutex Health experienced a 3.1% increase in total patient visits, reaching 49,742 in the first quarter of 2026. The company employed approximately 1,005 full-time employees and contracted with over 280 doctors, while partnering with more than 3,600 physicians across its networks. The company continues to expand its footprint, operating 27 hospital facilities across 12 states. However, the gross profit for the hospital division decreased to $89.6 million from $117.9 million, primarily due to increased arbitration costs, which rose to $46.1 million from $26.3 million in the previous year.
In terms of strategic developments, Nutex Health has been actively managing its stock repurchase programs. In March 2026, the company authorized a new stock repurchase program of up to $25 million, following the completion of a previous program. During the first quarter, Nutex repurchased 200,444 shares at an aggregate value of approximately $31.7 million. Additionally, the company entered into settlement agreements with former doctor owners of under-construction hospitals, resulting in the retirement of shares valued at $9.7 million during the quarter and an additional $13 million post-quarter.
The company’s financial position remains strong, with cash and cash equivalents totaling $207.3 million as of March 31, 2026, compared to $185.6 million at the end of 2025. Nutex Health reported cash provided by operating activities of $75.5 million, driven by higher net income and improved cash collections. The company also noted a decrease in corporate and other costs, which fell to $10.5 million from $37.7 million, largely due to reduced stock-based compensation expenses.
Looking ahead, Nutex Health anticipates continued growth in patient volumes and revenue, supported by its strategic initiatives in the population health management division and ongoing operational improvements. However, the company remains cautious about potential regulatory changes and market conditions that could impact its operations and financial performance. The management emphasized its commitment to navigating the complexities of the healthcare landscape while focusing on delivering quality care and enhancing shareholder value.
About Nutex Health, Inc.
Nutex Health Inc. operates a healthcare services platform with 24 micro-hospitals and physician networks across the U.S. Its core activities include developing innovative outpatient facilities, managing population health through IPAs, and providing comprehensive, patient-centric care. The company leverages physician partnerships, scalable models, and community-focused strategies to deliver high-quality emergency and primary care in high-demand markets.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.